Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

558.87
+13.412.46%
Post-market: 562.994.12+0.74%19:55 EDT
Volume:1.66M
Turnover:920.76M
Market Cap:60.34B
PE:14.17
High:583.28
Open:583.01
Low:542.89
Close:545.46
Loading ...
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities